Imatinib Mesylate
NDC 59651-241, Imatinib Mesylate, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 59651-241
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212773
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMATINIB MESYLATE400 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-241-03 | 59651024103 | 3 BLISTER PACK in 1 CARTON (59651-241-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 59651-241-30 | 59651024130 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-241-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a4e409f7-20b4-4c80-8a6a-f95995ffad78NADAC price for package 59651024130
GET /v1/drugs/nadac/59651024130
Use it
Look up 59651-241 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-241. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.